Progenics Pharmaceuticals begins Phase 3 study of 1404; prostate cancer …

Progenics Pharmaceuticals begins Phase 3 study of 1404; prostate cancer …

This Phase 3 clinical trial is expected to enroll approximately 450 patients with newly diagnosed low-grade prostate cancer who are candidates for active surveillance, but nonetheless are planning to undergo radical prostatectomy. This multi-center …

(Visited 4 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.